Company / PP&E per Share
Terns Pharmaceuticals, Inc. PP&E per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.00
FY2024
5-year range
$0.00 / $4.12
FY2020-FY2024
Trend
-60.7%
vs FY2023
Sector context
#181 of 194
Health Care
What the data says
Among 194 Health Care companies, Terns Pharmaceuticals, Inc. is in the bottom 7% for pp&e per share. PP&E per Share has declined for 4 consecutive years, from $4.12 in FY2020 to $0.00 in FY2024.
Based on SEC 10-K filings.
0.00 in FY2024 with a 3-year CAGR of -60.7%.
Declined from $0.02 to $0.00 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -60.7%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 7% in Health CareTop 93% of 194This company $0.00 Sector average $23.91
▼
-100.0% below sector average
Key checks
Key Insights
- Terns Pharmaceuticals, Inc.'s pp&e per share has declined for 4 consecutive years.
- In FY2024, pp&e per share decreased 60.7% year-over-year.
- Ranks #181 out of 194 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2020.
Company context
Key Data Points
- Altman Z-Score 7.86 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -60.7% |
| FY2023 | $0.01 | -66.2% |
| FY2022 | $0.02 | -54.4% |
| FY2021 | $0.05 | -98.9% |
| FY2020 | $4.12 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026